研究报告

格氏乳杆菌TF08-1的菌株特性及安全性评价

  • 杨埔 ,
  • 申瑾蓉 ,
  • 张丽珍
展开
  • (山西大学 生命科学学院,山西 太原,030006)
第一作者:博士,副教授(张丽珍教授为通信作者,E-mail:lizhen@sxu.edu.cn)

收稿日期: 2025-06-25

  修回日期: 2025-09-30

  网络出版日期: 2026-06-03

基金资助

山西省高等学校科技创新项目(2019L0104)

Properties and safety assessment of Lactobacillus gasseri TF08-1

  • YANG Pu ,
  • SHEN Jinrong ,
  • ZHANG Lizhen
Expand
  • (School of Life Science, Shanxi University, Taiyuan 030006, China)

Received date: 2025-06-25

  Revised date: 2025-09-30

  Online published: 2026-06-03

摘要

格氏乳杆菌(Lactobacillus gasseri)TF08-1是分离自健康人体粪便样本的一株益生菌,具有降脂、降糖、缓解体重增长等多种益生功能。为进一步开发利用,该文研究了该菌的抑菌能力和对环境胁迫的抗逆性,并对其安全性进行评价。结果显示,格氏乳杆菌TF08-1上清液对4种致病菌具有抑菌活性。上清液中高浓度L-乳酸导致的pH下降是抑菌机制之一。进一步研究表明,该菌对消化道具有较好的耐受性,并具有较强的自聚集率和黏附能力。该菌无溶血活性,不产生生物胺,未检出抗生素抗性,遗传稳定性较强,同时对小鼠无致病性。因此,格氏乳杆菌TF08-1具有较好的益生特性、抗逆性和安全性,可以进一步开发利用。

本文引用格式

杨埔 , 申瑾蓉 , 张丽珍 . 格氏乳杆菌TF08-1的菌株特性及安全性评价[J]. 食品与发酵工业, 2026 , 52(9) : 20 -28 . DOI: 10.13995/j.cnki.11-1802/ts.043695

Abstract

Lactobacillus gasseri TF08-1, a probiotic candidate isolated from the fecal of a healthy female, has been reported to alleviate conditions such as hyperlipidemia, diabetes mellitus and obesity.To facilitate its further application, the antibacterial activities, stress resistances and safety profile of L. gasseri TF08-1 were evaluated.The results demonstrated antibacterial activities of the cell-free supernatant of L. gasseri TF08-1 against four pathogens with L-lactic acid as one of the antibacterial agents.L. gasseri TF08-1 also showed resistance to stimulated oral, gastric and intestinal stresses, as well as autoaggregation and surface adhesion abilities.Additionally, L. gasseri TF08-1 lacked hemolysis, did not produce biogenic amine, and was sensitive to antibiotics.It was non-pathogenic to rat and maintained phenotypic and genetic stability within 20 generations.In conclusion, L. gasseri TF08-1 showed promising probiotic properties and stress resistance, and is safe for future application.

参考文献

[1] HUANG F, MA J W, YE Z F, et al.Lactobacillus gasseri:Screening, functional properties, and current applications in the food industry[J].Food Reviews International, 2025, 41(3):935-952.
[2] MANN S, PARK M S, JOHNSTON T V, et al.Oral probiotic activities and biosafety of Lactobacillus gasseri HHuMIN D[J].Microbial Cell Factories, 2021, 20(1):75.
[3] CHU A N, SAMMAN S, GALLAND B, et al.Daily consumption of Lactobacillus gasseri CP2305 improves quality of sleep in adults-A systematic literature review and meta-analysis[J].Clinical Nutrition, 2023, 42(8):1314-1321.
[4] KANO H, YAMADA N, SAITO C, et al.Lactobacillus gasseri PA-3, but not L.gasseri OLL2996, reduces the absorption of purine nucleosides in rats[J].Nucleosides, Nucleotides & Nucleic Acids, 2018, 37(6):353-360.
[5] ROOS S, DAHLGREN A L, MAO Y K, et al.Therapeutic value of Lactobacillus gasseri 345A in chronic constipation[J].Neurogastroenterology and Motility, 2025, 37(5):e70012.
[6] 张书灵, 唐鑫, 毛丙永, 等.格氏乳杆菌CCFM1346通过调节尿酸代谢和改善肾脏炎症缓解小鼠的高尿酸血症[J].食品与发酵工业, 2025, 51(3):52-57.
ZHANG S L, TANG X, MAO B Y, et al.Lactobacillus gasseri CCFM1346 alleviates hyperuricemia in mice by regulating uric acid metabolism and improving kidney inflammation[J].Food and Fermentation Industries, 2025, 51(3):52-57.
[7] WANG M M, HU T Y, LIN X Q, et al.Probiotic characteristics of Lactobacillus gasseri TF08-1:A cholesterol-lowering bacterium, isolated from human gut[J].Enzyme and Microbial Technology, 2023, 169:110276.
[8] LEE M, BANG W Y, LEE H B, et al.Safety assessment and evaluation of probiotic potential of Lactobacillus bulgaricus IDCC 3601 for human use[J].Microorganisms, 2024, 12(10):2063.
[9] 滕堃如, 李斌, 陈红贺, 等.市售益生菌剂产品活性检测及其模拟胃消化耐受性[J].食品与发酵工业, 2024, 50(20):57-63;71.
TENG K R, LI B, CHEN H H, et al.Viability and simulated gastric digestion tolerance of commercial probiotic products[J].Food and Fermentation Industries, 2024, 50(20):57-63;71.
[10] TIAN S Q, JIANG Y H, HAN Q N, et al.Putative probiotic Ligilactobacillus salivarius strains isolated from the intestines of meat-type pigeon squabs[J].Probiotics and Antimicrobial Proteins, 2025, 17(5):3338-3357.
[11] ZHANG J Y, DUAN Z.Identification of a new probiotic strain, Lactiplantibacillus plantarum VHProbi V38, and its use as an oral health agent[J].Frontiers in Microbiology, 2022, 13:1000309.
[12] RYCHEN G, AQUILINA G, AZIMONTI G, et al.Guidance on the characterisation of microorganisms used as feed additives or as production organisms[J].EFSA Journal, 2018, 16(3):e05206.
[13] 薛梅, 刘东方, 桑建, 等.鼠李糖乳杆菌LV108传代的稳定性[J].中国乳品工业, 2016, 44(7):15-19.
XUE M, LIU D F, SANG J, et al.Research on subculture and genetic stability of Lactobacillus rhamnosus LV108[J].China Dairy Industry, 2016, 44(7):15-19.
[14] CIZEIKIENE D, JAGELAVICIUTE J.Investigation of antibacterial activity and probiotic properties of strains belonging to Lactobacillus and Bifidobacterium genera for their potential application in functional food and feed products[J].Probiotics and Antimicrobial Proteins, 2021, 13(5):1387-1403.
[15] 胡静怡, 杨波, 赵建新, 等.产不同细菌素的格氏乳杆菌对小鼠肠道微生态的影响[J].食品与生物技术学报, 2024, 43(6):1-10.
HU J Y, YANG B, ZHAO J X, et al.Effect of Lactobacillus gasseri with different bacteriocins production on the intestinal micro-ecology in mice[J].Journal of Food Science and Biotechnology, 2024, 43(6):1-10.
[16] CHEN X H, LIU X M, TIAN F W, et al.Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells[J].Journal of Food Science, 2012, 77(1):M9-M14.
[17] LUO Y, DE SOUZA C, RAMACHANDRAN M, et al.Precise oral delivery systems for probiotics:A review[J].Journal of Controlled Release, 2022, 352:371-384.
[18] ASADI A, LOHRASBI V, ABDI M, et al.The probiotic properties and potential of vaginal Lactobacillus spp.isolated from healthy women against some vaginal pathogens[J].Letters in Applied Microbiology, 2022, 74(5):752-764.
[19] WANG S H, LI L L, YU L L, et al.Natural aggregation of Lactobacillus:Mechanisms and influencing factors[J].Food Bioscience, 2024, 62:105007.
[20] FERREIRA C L, GRZES·KOWIAK L, COLLADO M C, et al.In vitro evaluation of Lactobacillus gasseri strains of infant origin on adhesion and aggregation of specific pathogens[J].Journal of Food Protection, 2011, 74(9):1482-1487.
[21] VAN ZYL W F, DEANE S M, DICKS L M T.Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria[J].Gut Microbes, 2020, 12(1):1831339.
[22] SANDERS M E, AKKERMANS L M A, HALLER D, et al.Safety assessment of probiotics for human use[J].Gut Microbes, 2010, 1(3):164-185.
[23] ORF K, CUNNINGTON A J.Infection-related hemolysis and susceptibility to Gram-negative bacterial co-infection[J].Frontiers in Microbiology, 2015, 6:666.
[24] DEL RIO B, FERNANDEZ M, REDRUELLO B, et al.New insights into the toxicological effects of dietary biogenic amines[J].Food Chemistry, 2024, 435:137558.
[25] 李雄超, 张卫兵, 梁琪, 等.高产胞外多糖干酪乳杆菌的太空诱变选育[J].食品工业科技, 2014, 35(18):185-188;193.
LI X C, ZHANG W B, LIANG Q, et al.Mutation of Lactobacillus casei with high production of exopolysaccharides by space mutagenesis[J].Science and Technology of Food Industry, 2014, 35(18):185-188;193.
[26] WANG T Y, GU C T.Lactiplantibacillus paraxiangfangensis sp.nov., isolated from traditional Chinese pickle[J].International Journal of Systematic and Evolutionary Microbiology, 2024, 74(3):e006278.
文章导航

/

〈 〉